Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2015 2
2016 2
2017 4
2018 3
2020 1
2021 1
2022 1
2023 3
2024 1
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 24222661

21 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial.
Piffoux M, Leary A, Follana P, Abdeddaim C, Joly F, Bin S, Bonjour M, Boulai A, Callens C, Villeneuve L, Alexandre M, Schwiertz V, Freyer G, Rodrigues M, You B. Piffoux M, et al. Nat Commun. 2025 Feb 20;16(1):1821. doi: 10.1038/s41467-025-56914-7. Nat Commun. 2025. PMID: 39979249 Free PMC article. Clinical Trial.
Rat Models of Hormone Receptor-Positive Breast Cancer.
Nicotra R, Lutz C, Messal HA, Jonkers J. Nicotra R, et al. J Mammary Gland Biol Neoplasia. 2024 Jun 24;29(1):12. doi: 10.1007/s10911-024-09566-0. J Mammary Gland Biol Neoplasia. 2024. PMID: 38913216 Free PMC article. Review.
Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.
EFSA Panel on Plant Protection Products and their Residues (PPR); Hernandez-Jerez AF, Adriaanse P, Aldrich A, Berny P, Coja T, Duquesne S, Focks A, Millet M, Pelkonen O, Pieper S, Tiktak A, Topping CJ, Widenfalk A, Wilks M, Wolterink G, Angeli K, Recordati C, Van Durseen M, Aiassa E, Lanzoni A, Lostia A, Martino L, Guajardo IPM, Panzarea M, Terron A, Marinovich M. EFSA Panel on Plant Protection Products and their Residues (PPR), et al. EFSA J. 2023 Feb 14;21(2):e07744. doi: 10.2903/j.efsa.2023.7744. eCollection 2023 Feb. EFSA J. 2023. PMID: 36818642 Free PMC article.
PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives.
Musacchio L, Caruso G, Pisano C, Cecere SC, Di Napoli M, Attademo L, Tambaro R, Russo D, Califano D, Palaia I, Muzii L, Benedetti Panici P, Pignata S. Musacchio L, et al. Cancer Manag Res. 2020 Jul 22;12:6123-6135. doi: 10.2147/CMAR.S221001. eCollection 2020. Cancer Manag Res. 2020. PMID: 32801862 Free PMC article. Review.
21 results